Individualized continuation electroconvulsive therapy and medication as a bridge to relapse prevention after an index course of electroconvulsive therapy in severe mood disorders: A naturalistic 3-year cohort study

Journal of ECT

Volumn 24, Issue 3, 2008, Pages 183-190

  Odeberg, Hålkan ^a,b   Rodriguez Silva, Bruce ^b   Salander, Pirjo ^b   Mårtensson, Björn ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Department of Psychiatry   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Continuation electroconvulsive therapy; Continuation pharmacotherapy; Electroconvulsive therapy; Mood disorder; Relapse prevention

Indexed keywords

CARBAMAZEPINE; CITALOPRAM; CLOMIPRAMINE; CLONAZEPAM; CLOZAPINE; DIXYRAZINE; FLUPENTIXOL; HALOPERIDOL; LEVOMEPROMAZINE; LITHIUM; MIANSERIN; MIRTAZAPINE; OLANZAPINE; PERPHENAZINE; PHENELZINE; RISPERIDONE; TOPIRAMATE; TRANYLCYPROMINE; TRIMIPRAMINE; VALPROIC ACID; VENLAFAXINE; ZIPRASIDONE; PSYCHOTROPIC AGENT;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AFFECTIVE PSYCHOSIS; AGED; AGITATED DEPRESSION; AGITATION; ANXIETY; ARTICLE; BIPOLAR DEPRESSION; CATATONIA; CLINICAL ARTICLE; CLINICAL EVALUATION; COHORT ANALYSIS; DEFENSE MECHANISM; DISORIENTATION; DRUG INTOXICATION; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; EMOTIONAL DISORDER; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HOPELESSNESS; HOSPITAL ADMISSION; HOSPITAL CARE; HOSPITALIZATION; HOSTILITY; HUMAN; LENGTH OF STAY; MAJOR DEPRESSION; MALE; MANIA; MEDICAL RECORD REVIEW; RECURRENT DISEASE; RELAPSE; RETROSPECTIVE STUDY; SOMATIZATION; SUBSTANCE ABUSE; THERAPY RESISTANCE; TREATMENT DURATION; TREATMENT RESPONSE; ADDICTION; CASE REPORT; CHRONIC DISEASE; DEPRESSION; METHODOLOGY; MIDDLE AGED; MOOD DISORDER; MULTIMODALITY CANCER THERAPY; PATIENT CARE; PSYCHOLOGICAL ASPECT; PSYCHOSIS; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANXIETY; CHRONIC DISEASE; COHORT STUDIES; COMBINED MODALITY THERAPY; DEPRESSION; ELECTROCONVULSIVE THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MOOD DISORDERS; PATIENT-CENTERED CARE; PSYCHOTIC DISORDERS; PSYCHOTROPIC DRUGS; RECURRENCE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 58749116814     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/YCT.0b013e318177275d     Document Type: Article

References (35)

1. Seager CP, Bird RL. Imipramine with electrical treatment in depression - a controlled trial. J Ment Sci. 1962;108:704-707.
2. Imlah NW, Ryan E, Harrington JA. The influence of antidepressant drugs on the response to electroconvulsive therapy and on subsequent relapse rates. Neuropsychopharmacology. 1965;4:438-442.
3. Sackeim HA, Prudic J, Devanand DP, et al. The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol. 1990;10:96-104.
4. Sackeim HA, Haskett RF, Mulsant BH, et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA. 2001;285:1299-1307.
5. Sackeim HA, Prudic J, Devanand DP, et al. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry. 2000;57:425-434.
6. Bourgon LN, Kellner CH. Relapse of depression after ECT: a review. J ECT. 2000;16:19-31.
7. Tew JD, Mulsant BH, Haskett RF, et al. Relapse during continuation pharmacotherapy after acute response to ECT: a comparison of usual care versus protocolized treatment. Ann Clin Psychiatry. 2007;19:1-4.
8. American Psychiatric Association. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging. 2nd ed. Washington DC: American Psychiatric Association Press; 2001.
9. Fink M. ECT in therapy-resistant mania: does it have a place? Bipolar Disord. 2006;8:307-309.
10. Andrade C, Kurinji S. Continuation and maintenance ECT: a review of recent research. J ECT. 2002;18:149-158.
11. Frederikse M, Petrides G, Kellner C. Continuation and maintenance electroconvulsive therapy for the treatment of depressive illness: a response to the national institute for clinical excellence report. J ECT. 2006;22:13-17.
12. Wijkstra J, Nolen WA, Algra A, et al. Relapse prevention in major depressive disorder after successful ECT: a literature review and a naturalistic case series. Acta Psychiatr Scand. 2000;102:454-460.
13. Kellner CH, Knapp RG, Petrides G, et al. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry. 2006;63:1337-1344.
14. Suzuki K, Awata S, Takano T, et al. Adjusting the frequency of continuation and maintenance electroconvulsive therapy to prevent relapse of catatonic schizophrenia in middle-aged and elderly patients who are relapse-prone. Psychiatry Clin Neurosci. 2006;60:486-492.
15. Russell JC, Rasmussen KG, O'Connor MK, et al. Long-term maintenance ECT: a retrospective review of efficacy and cognitive outcome. J ECT. 2003;19:4-9.
16. Swoboda E, Conca A, König P, et al. Maintenance electroconvulsive therapy in affective and schizoaffective disorder. Neuropsychobiology. 2001;43:23-28.
17. Vanelle JM, Loo H, Galinowski A, et al. Maintenance ECT in intractable manic-depressive disorders. Convuls Ther. 1994;10:195-205.
18. Gagne GG Jr, Furman MJ, Carpenter LL, et al. Efficacy of continuation ECT and antidepressant drugs compared to long-term antidepressants alone in depressed patients. Am J Psychiatry. 2000;157:1960-1965.
19. Schwarz T, Loewenstein J, Isenberg KE. Maintenance ECT: indications and outcome. Convuls Ther. 1995;11:14-23.
20. Serra M, Gastó C, Navarro V, et al. Tratamiento electroconvulsivo de mantenimiento en la depresión unipolar psicótica del anciano [Maintenance electroconvulsive therapy in elderly psychotic unipolar depression]. Med Clin (Barc). 2006;126:491-492.
21. Guy W. Clinical global impressions (CGI). In: ECDEU Assessment Manual for Psychopharmacology. Washington, DC: US Department of Health and Human Services, Public Health Service, Alcohol Drug Abuse and Mental Health Administration, NIMH Psychopharmacology Research Branch; 1976:218-222.
22. Montgomery SA, Asberg M. A new rating scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-389.
23. Coppen A, Abou-Saleh MT, Milln P, et al. Lithium continuation therapy following electroconvulsive therapy. Br J Psychiatry. 1981;139:284-287.
24. Baldessarini RJ, Tondo L, Hennen J. Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders. J Clin Psychiatry. 1999;60(suppl 2):77-84; discussion 111-116.
25. Baldessarini RJ, Tondo L, Viguera AC. Discontinuing lithium maintenance treatment in bipolar disorders: risks and implications. Bipolar Disord. 1999;1:17-24.
26. Viguera AC, Nonacs R, Cohen LS, et al. Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry. 2000;157:179-184.
27. Fink M. What can we learn about continuation treatments from the collaborative electroconvulsive therapy studies. Commentary. J ECT. 2007;23:215-218.
28. Vothknecht S, Kho KH, van Schaick HW, et al. Effects of maintenance electroconvulsive therapy on cognitive functions. J ECT. 2003;19:151-157.
29. Rami L, Bernardo M, Valdes M, et al. Absence of additional cognitive impairment in schizophrenia patients during maintenance electroconvulsive therapy. Schizophr Bull. 2004;30:185-189.
30. Rami L, Bernardo M, Boget T, et al. Cognitive status of psychiatric patients under maintenance electroconvulsive therapy: a one-year longitudinal study. J Neuropsychiatry Clin Neurosci. 2004;16:465-471.
31. Barnes RC, Hussein A, Anderson DN, et al. Maintenance electroconvulsive therapy and cognitive function. Br J Psychiatry. 1997;170:285-287.
32. Bolwig TG, Madsen TM. Electroconvulsive therapy in melancholia: the role of hippocampal neurogenesis. Acta Psychiatr Scand. 2007;115 (suppl 433):130-135.
33. Deckersbach T, Dougherty DD, Savage C, et al. Impaired recruitment of the dorsolateral prefrontal cortex and hippocampus during encoding in bipolar disorder. Biol Psychiatry. 2006;59:138-146.
34. Brown ES, Rush AJ, McEwen BS. Hippocampal remodeling and damage by corticosteroids: implications for mood disorders. Neuropsychopharmacology. 1999;21:474-484.
35. Manji HK, Moore GJ, Chen G. Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness. Biol Psychiatry. 2000;48:740-754.